logo
As Americans Eat Less, Food-Inspired Scents Trend Hard

As Americans Eat Less, Food-Inspired Scents Trend Hard

Forbes29-03-2025
Goodbye Santal33. Hello, tropical fruits, rice and potatoes.
A Cornell study published at the end of 2024 revealed that there has been an 8.6% decline in spending at fast-food chains, coffee shops, and limited-service restaurants, and households with at least one GLP-1 user cut their spending on groceries by around 6%. The grocery items taking the biggest hits - chips, cookies and other baked goods - bear similarities to the scents that are trending.
Even if you're not on GLP-1s, none of us hasn't noticed that 'thin is in' means 'food is out.' Is the pressure enough to make us want to smell (or smell like) the things we're being told we shouldn't be eating? Is it possible that we as a culture are creating proxy experiences for eating through scent? I asked two perfumers, one perfume blogger, one therapist, one dietician, and a beauty industry reporter to give me their hot takes.
Polish Potatoes by BohoBoco
Though I'm a seasoned critic of diet culture (of which GLP-1s are certainly a part) and a plus-size woman recovering from years of food restriction, I will not profess to be a scent expert. I'm a humble, new fan to PerfumeTok. My bathroom sink is lined with everything from Kilian to Ranger Station, from Rita's Car to an off-brand bottle of creme brulee body spray that I got at Marshall's one time. Due to writing this article, I am now $26 poorer having purchased a Snif sample perfume pack that has four scents, including one that smells like pizza.
I'm not on GLP-1s, and am glad I have the option to smell like a slice because it sounds fun.
Further, it's only fair to point out that smelling good – whether it's through gourmands, florals or woody smells, like the iconic Le Labo Santal 33 – is timeless and driven by many forces. Additionally, designer brands are no longer the only perfume game in town. We seem to be in a perfume renaissance right now with unprecedented access (and demand for) playful and experimental scents, as well as smells that go beyond the traditional European canon. Finally, There is no singular answer to the question, 'What scents are trending?' Nor is there a simple answer to the question, 'How does a scent trend happen?' As Yosh Han, perfumer and Creative Director at Scent Trunk, put it, 'You can't separate scent from culture. How perfume engages with our entire life is much deeper than most people are aware of.'
Many would say that connecting scent trends to GLP-1s is a stretch. However, as someone who studies diet culture and knows intimately how it touches unexpected parts of our lives, there's something about croissant-inspired perfume emerging during a weight-loss trend the likes of which we haven't seen in two decades, that raises an eyebrow.
'You can't separate scent from culture. How perfume engages with our entire life is much deeper than most people are aware of.'
Yosh Han is a perfumer and Creative Director at Scent Trunk
In a November 2024 WhoWhatWear article titled, 'Scent Experts Say These 4 Major Fragrance Trends Will Define 2025,' columnist Kaitlyn McClintock wrote, 'Gourmand perfumes (aka, sweet scents with 'edible' notes like chocolate, cream, sugar, vanilla, etc.) are having a moment. Actually, that's not true. It's more than a moment. They've been having a year.' In January, Elle published an article titled '5 Perfume Trends to Watch in 2025,' asserting, 'In 2025, scents are continuing in a decidedly delicious direction. Most of the big fragrance trends revolve around food."
Gourmands aren't exactly new. We all know about the ubiquity of vanilla scents, for example. This new iteration of food scents, though, brings in a veritable feast of smells that go beyond the traditional gourmand territory, like milk, matcha, toasted sesame, tropical fruits, and croissant.
'I definitely think that the popularity of food-inspired beauty products, and gourmand scents in particular, speaks to a sublimated desire for the things we don't or won't eat in the age of Ozempic,' says Jessica Defino, a beauty reporter and author of The Review of Beauty newsletter. 'I even got a press release the other day for a 'lickable perfume' (called Late Night Gelato) from Amorecco." Defino said it reminded her of the early 2000s beauty brand, Dessert Treats, by Jessica Simpson. 'All the body sprays were edible and tasted like cookies or ice cream, and this was right at the time when ephedra weight loss pills were a huge cultural phenomenon. So yes, it seems striking to me that gourmand and even edible scents are trending now and were trending when the last big new weight- loss technology was popular.'
'..it seems striking to me that gourmand and even edible scents are trending now and were trending (in the early 2000s) when the last big new weight-loss technology was popular.'
Crumb Couture is a croissant-inspired scent from Snif
As we got deeper into his interview, however, he wrote, 'When food consumption is decreased, there may still be a desire for the sensory satiety, comfort and familiarity that eating brings. You may consume less chocolate, but wearing a gourmand fragrance can serve as a decadent and sensory substitute."
Terry Carter, CEO of Travertine Atelier
The conversation with Carter had unexpectedly stirred up childhood memories of my aunt, a lifelong dieter and weight cycler. I could always tell she was starting a new diet because, in addition to eating noticeably less, she often asked me if she could smell all my food before I ate it at dinner. I wanted to talk to someone who understands the relationship between restricting food and feeling compelled to substitute tasting with smelling.
I reached out to Signe Darpinian, a therapist and certified eating disorder specialist with over 20 years of experience. Interestingly, her words echoed Carter's. "We have evolved to need to have pleasure with our food," says Darpinian. 'A person can feel the physical sensation of fullness without feeling the emotional and psychological pleasure of satisfaction. People need and crave both.' Darpinian concluded that you can't really trick the brain. Fullness without pleasure is incomplete. This lop-sided reality might lead to seeking alternative methods – like using the sense of smell – to attempt to access that emotional side of eating.
'A person can feel the physical sensation of fullness without feeling the emotional and psychological pleasure of satisfaction. People need and crave both.'
Auntie Anne's Pretzels scent Knead, Eau de Pretzel
Wendy Sterling is a dietitian, who further explained the connection between food restriction, smell and pleasure. 'When the body is in a state of energy deprivation, whether due to an eating disorder, dieting, or medications that suppress appetite, the brain becomes hyper-focused on seeking food. Scents and flavors become more intense.' Sterling says this can lead to people scrolling through food reels on TikTok or lingering by bakeries. 'It's the brain's clever way of urging someone to eat while tricking them into thinking they have experienced pleasure.' She says it's all part of our hardwired drive toward survival and nourishment. 'The olfactory system plays a key role in this process, as smell is deeply connected to taste and the brain's reward pathways.'
Though Darpinian's and Sterling's words spoke to a clear connection between food deprivation and smell, I wanted to see if that connection could be more clearly extended to the gourmand and food scents trend. I returned to Yosh Han and Christina Loff, author of the perfume-focused Substack 'The Dry Down Diaries.' Loff was skeptical. 'Gourmand scents have been growing in popularity for years, well before (GLP-1s) entered the public conversation or even existed. I'm not convinced there's a true correlation.' Han, on the other hand, was more open to the possibility. 'Maybe you're not able to eat a croissant, but you can still enjoy the smell of a croissant.'
'Maybe you're not able to eat a croissant, but you can still enjoy the smell of a croissant.'
By the end of my interviews, I found myself settling into three conclusions: that the GLP-1 trend has affected how Americans relate to food, that food restriction can affect how humans relate to smell, and that what we want to smell (and smell like) is related to this cultural moment, which is defined, in part, by the GLP-1 trend. Where and whether those conclusions intersect depends on your vantage point. The next time you reach for that perfume that smells (and possibly tastes) like a freshly made buttery pretzel, let me know where you stand.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The best herpes test kits for 2025, according to experts
The best herpes test kits for 2025, according to experts

Yahoo

time3 hours ago

  • Yahoo

The best herpes test kits for 2025, according to experts

Herpes affects billions of people around the world. In fact, the World Health Organization reports that 3.8 billion people under the age of 50 have herpes simplex virus type 1 (HSV-1), the main cause of oral herpes, while an estimated 520 million people ages 15 to 49 have herpes simplex virus type 2 (HSV-2), the main cause of genital herpes. Yet, despite how prevalent this infection is, when going to your doctor specifically for a sexually transmitted infection (STI) panel, herpes is not typically included in the screening. Fortunately, there are at-home herpes test kits that can give you the answers you need without a trip to the doctor."At-home tests are generally reliable when used correctly," says Dr. Stephanie Hack, board-certified obstetrician and gynecologist. In the U.S., where there are roughly 572,000 new cases of genital herpes in individuals between the ages of 14 and 49 each year, at-home testing can be a reliable part of regular sexual health screenings. But Dr. Hack notes that not all herpes tests are created equal. A key point to keep in mind — you don't want to buy just any old test and hope for the best. When it comes to testing for herpes, you want to make sure the test you choose is accurate and easy to help us understand what to look for in the best at-home herpes tests, we spoke with a panel of four medical experts who specialize in sexual and reproductive health to get their input on self-administered herpes tests. We then used the experts' input and my own experience as a health care professional and health journalist to research the top OTC herpes tests, rating each based on cost, ease of use, time to receive results and any additional medical support offered. Here are our picks for the best at-home herpes tests for a range of needs. However, if you're concerned about other sexually transmitted infections as well, consider our top picks for the best at-home STD tests and best at-home syphilis tests. Best at-home herpes test overall Other top at-home herpes tests we recommend for 2025 Factors to consider when choosing an at-home herpes test How we chose the best at-home herpes test FAQs Meet our experts Update, July 2, 2025: We checked all product prices and availability. Our No. 1 pick for the best at-home herpes test remains unchanged. (back to top) (back to top) Choosing the right herpes test for you is a personal decision that depends on your specific needs. Before making a decision, it's a good idea to consider certain factors: Type of test: HSV-1 is generally considered the virus responsible for oral herpes, whereas genital herpes is associated more with HSV-2. However, since genital herpes can come from either herpes virus, tests that look for both types of of the virus tend to be more accurate. On the other hand, tests that screen only for HSV-2 are typically more cost-effective. Collection method: Herpes can be detected using a blood sample or a swab of the lesion if an outbreak is present. According to Dr. Jill Purdie, board-certified ob/gyn in Alpharetta, Ga., taking a swab of the sore itself is the most accurate type of test, but it's also more prone to user error than a blood sample. A swab sample also requires an active outbreak, whereas a blood test can determine whether or not you've been exposed to the virus even when an outbreak is not present. Time until results: The last thing you want to do when getting an STD test is sit around and wait for the results. Certain tests offer shorter wait times, while others might take a bit longer. All the tests on this list have a turnaround time of between one and five days. Medical support included: If you test positive, does the company offer any type of medical support? If a medical consultation is available, is it free or does it cost extra? Additionally, is treatment or a prescribing provider available? Cost: Along with the cost of the actual test, consider whether or not there are additional fees for shipping, follow-up support or treatment options. Also, consider whether or not FSA/HSA payments are accepted. Accuracy: For the most accurate results, look for a company that uses CAP- and CLIA-certified labs. Privacy: Most at-home herpes tests don't accept insurance or require extensive identifying information outside of name and address, which can go a long way toward protecting your privacy. Additionally, look for a company that offers discreet packaging when shipping. (back to top) To find the best at-home herpes tests on the market today, we first consulted a panel of medical experts who specialize in sexual health, urology and reproductive and women's health. Our team then researched a broad range of at-home HSV tests and rated each based on cost, the type of herpes viruses tested, accuracy, collection method and turnaround time. In addition, we considered the company's reputation and follow-up support. Specifically, we looked at whether or not the option for a health care consultation or treatment was available. After compiling the data, we narrowed our list of the best herpes tests based on specific testing needs, such as turnaround time and additional medical support. (back to top) Herpes is primarily detected in one of two ways: through antibodies in the blood or by the presence of the virus in a lesion. Urine tests are less common but can be used in combination with another sample method to ensure accuracy. To date, there are not any fully at-home rapid tests that can detect the herpes virus, so all "at-home" tests require you to pre-purchase the test online, then collect the sample yourself and mail it to the lab or visit a certified lab to have the sample specimen taken for you. Regardless of the option you choose, at-home herpes enable you to get tested without making an appointment with your primary care doctor. Herpes is a virus that causes skin infections and painful sores on the body, primarily around the mouth and genital areas. Aleece Fosnight, a board-certified physician assistant specializing in sexual medicine, women's health, and urology, tells us: "There are several types of herpes including varicella-zoster, the virus responsible for chicken pox. But the herpes simplex virus — or HSV — comes in two forms: HSV-1 mainly causes oral herpes — also known as cold sores HSV-2 is associated with genital herpes HSV-1 is spread through skin-to-skin contact and saliva and mainly causes oral herpes, also known as cold sores. HSV-2, on the other hand, is usually spread through sexual contact, resulting in genital herpes. Although herpes is most contagious during an outbreak, herpes simplex 1 and 2 can also be transmitted when there are no visible sores or symptoms. Unlike most other STDs that can only be spread through bodily fluids, HSV-1 and 2 can be transmitted through close skin-to-skin contact. "Both types of herpes can cause small, painful blisters around the site of the infection," says Dr. Rashid Bani, medical director at Your Sexual Health. Moreover, both types can infect your face or genitals. Although HSV-2 is responsible for most cases of genital herpes, you can get genital herpes from HSV-1 (and vice versa). Painful sores or blisters are the most common symptom of herpes, Purdie tells us. With oral herpes, there is typically just one blister, whereas genital herpes often appears in a cluster. Other common signs can include: Fever or flu-like symptoms Headaches Body and muscle aches Swollen lymph nodes in the neck or groin area Tingling, burning or itching sensation Unusual vaginal discharge Painful urination It's important to note, though, that not everyone who's infected with herpes will show symptoms. In fact, most people with HSV are asymptomatic and may not even realize they have it. You should get tested if you begin to experience symptoms or notice any sores around your genitals, says Hack. One exception would be if you've had sex with a partner who has genital herpes. In that case, it's important to remember that it can take time for your body to develop HSV antibodies. The incubation period for herpes is typically two to 12 days, but it can take even longer. In some cases, it can take up to 16 weeks or more for HSV to be detected in your blood, Fosnight says. Our experts agree that at-home tests are generally reliable when used correctly, so it's crucial you follow the directions for sample collection exactly as stated by the company. While the most accurate way to detect herpes is through a viral culture or PCR test via a swab of the blister or lesion, "blood tests, which look for HSV antibodies in a blood sample, can be used if you don't have an active outbreak or sore," says Hack. If you test positive for herpes, the next step should be to consult a healthcare provider to discuss possible treatment options. While there is no cure, treatments are available to help speed up healing, prevent or shorten outbreaks and reduce the chances of spreading it to partners. Your doctor may also advise getting retested after a positive test result, especially if you have no symptoms. "No HSV test is perfect, and false results can occur," says Hack. For example, one study found that herpes IgM testing resulted in many false positives for HSV-2 and many false negatives for HSV-1. False negatives can occur if the infection is very new since your body hasn't developed the antibodies yet. On the other hand, false positives can occur due to cross-reactivity. Antibody tests can sometimes react to other viruses in the same family (e.g., HSV-1 or the varicella-zoster virus). In other words, you may test positive for herpes type 2 when, in fact, you only have type 1. Because of that, it's always a good idea to discuss your results and sexual history with a doctor. (back to top) Dr. Stephanie Hack, board-certified obstetrician and gynecologist Dr. Jill Purdie, board-certified ob/gyn in Alpharetta, Ga. Aleece Fosnight, a board-certified physician assistant specializing in sexual medicine Dr. Rashid Bani, medical director at Your Sexual Health (back to top) Our health content is for informational purposes only and is not intended as professional medical advice. Consult a medical professional on questions about your health.

On the hunt for cheap stocks due for a second half bounce with Morningstar
On the hunt for cheap stocks due for a second half bounce with Morningstar

CNBC

time4 hours ago

  • CNBC

On the hunt for cheap stocks due for a second half bounce with Morningstar

Health care stocks could be the place to hide out for investors bracing for what many expect will be a volatile second half of the year. The industry is just starting to outperform, as traders rotate into a sector that is starting to look cheap after lagging this year. S & P 500 health care stocks are selling at 17 times forward earnings, far below their historical valuation. The entire S & P 500 sells for 23 times forward P/E. Exclude Eli Lilly , a high-flier thanks to its diabetes- and obesity treatments, and health care looks even more attractively valued. Lilly trades at 36 times forward earnings. "Healthcare looks very undervalued to us here, especially because healthcare is skewed to the upside, because [of] Eli Lilly," said Dave Sekera, chief U.S. market strategist for Morningstar. "Eli Lilly is overvalued. We think the market is over extrapolating the amount of profitability and growth in the GLP-1 drugs, which Eli Lilly, of course, is, you know, the the poster child for today." "If you were to take that out, the healthcare sector, as a sector, looks even more undervalued today," Sekera said, presenting an opportunity for investors. .GSPHC YTD mountain S & P 500 health care sector, year to date On Tuesday, the Dow Jones Industrial Average , which contains health care giants UnitedHealth Group , Johnson & Johnson , Amgen and Merck rallied, while the S & P 500 and Nasdaq Composite, which are weighted toward tech stocks that led the recent advance, retreated. Health care's relatively cheap valuations and above-average dividend yields give investors a "margin of safety" heading into the second half of the year, when the S & P 500 starts to look fairly valued at the same time as risks from tariffs and federal deficits continue, Sekera said. The strategist said he likes other beaten down parts of the market too, citing a preference for value stocks over growth issues and small caps over large caps. "Right now, I would actually prefer to see a greater margin of safety in the marketplace as a cushion for absorbing that amount of risk ," Sekera said. "With the market being at fair value, I think positioning is ever more important than usual."

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta
Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

Business Upturn

time7 hours ago

  • Business Upturn

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

Business Wire India Follitropin delta starting dose of 15 micrograms (µg)/day has comparable efficacy and safety as a starting dose of 225 International Units (IU)/day of follitropin alfa for ovarian stimulation in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) gonadotrophin-releasing hormone (GnRH) antagonist protocol cycles. This is the key finding of a trial presented today at the European Society of Human Reproduction and Embryology (ESHRE) Congress in Paris and published in Human Reproduction. These data build on previous studies which have established an estimated point of clinical correspondence for 10 µg follitropin delta to 150 IU follitropin alfa in this class of medications.1,2 The ADAPT-1 trial was a multicentre, randomised, assessor-blind study involving 300 women aged 18-40 years undergoing IVF or ICSI.3 The trial compared the efficacy and safety of follitropin delta and follitropin alfa using conventional dosing regimens with a primary endpoint of number of oocytes retrieved. Currently, follitropin delta is approved for use via a dosing algorithm based on serum anti-Müllerian Hormone (AMH) and bodyweight individualised for each patient, and aims to obtain an ovarian response which is associated with a favourable safety/efficacy profile. The clinical value of this approach has been well established4,5,6,7,8, particularly in treatment-naïve patients where the algorithm aims to achieve 8–14 retrieved oocytes while minimising the risk of ovarian hyperstimulation syndrome (OHSS) to optimise the live birth rate in a fresh and frozen transfer cycle.4,5,6,7,8 Key Findings: Ovarian Response: Both treatment groups achieved a mean of 9.9 oocytes retrieved, indicating similar efficacy Both treatment groups achieved a mean of 9.9 oocytes retrieved, indicating similar efficacy Clinical Pregnancy Rates: Clinical pregnancy rates were similar for follitropin delta 31.6% versus 31.0% for follitropin alfa Clinical pregnancy rates were similar for follitropin delta 31.6% versus 31.0% for follitropin alfa Drug Product Usage: After measurement unit conversion, the mean total dose patients were exposed to was numerically lower for follitropin delta (143.7±33.6 µg) than follitropin alfa (154.3±23.1 µg or 2,105±315 IU) After measurement unit conversion, the mean total dose patients were exposed to was numerically lower for follitropin delta (143.7±33.6 µg) than follitropin alfa (154.3±23.1 µg or 2,105±315 IU) OHSS Rates: Early OHSS rates were low (2.5% for follitropin delta and 3.0% for follitropin alfa), with no cycle cancellations due to excessive ovarian response on either arm of the study. Dr Andrea Bernabeu, Medical Director at Instituto Bernabeu and principal investigator of the ADAPT-1 trial, said: "No patients we see as fertility doctors are the same and the ability to optimise therapy based on patients age, treatment goal and whether they have a high or low response to follicular stimulation are all relevant. These data provide confidence and expand our understanding for dosing in follitropin delta." Pierre-Yves Berclaz, Chief Science and Medical Officer at Ferring Pharmaceuticals, stated: "The ADAPT-1 trial results confirm the efficacy and safety of follitropin delta across the full range of dosing strategies, making it the only recombinant FSH with robust clinical evidence supporting multiple dosing strategies. Ferring will take forward the implications of this study in future dialogue with regulatory authorities." About GnRH protocols Gonadotrophin-releasing hormone (GnRH) agonists and antagonists are used as concomitant treatment during ovarian stimulation to prevent premature luteinisation and ovulation for IVF/ICSI.7,8 About Follitropin Delta (Rekovelle®) Follitropin delta is a human cell line-derived rFSH with an approved dosing algorithm designed for a predictable ovarian response.3 It is the first rFSH derived from a human cell line (PER.C6® cell line). Follitropin delta is structurally and biochemically distinct from other existing rFSH gonadotrophins.3,4 Follitropin delta is approved in certain markets for use in controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART), such as IVF or ICSI cycle. The individualised dosing of follitropin delta is determined using an approved algorithm, based on a woman's AMH level and body weight.3,5 AMH is a biomarker used to assess ovarian reserve and can help predict ovarian response.5,6 The follitropin delta dose should be based on AMH level, measured using the ELECSYS AMH Plus immunoassay from Roche, the ACCESS AMH Advanced from Beckman Coulter, or LUMIPULSE G AMH from Fujirebio.3 About Ferring Pharmaceuticals Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine with a strong heritage in areas of gastroenterology and urology, and are at the forefront of innovation in uro-oncology gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which market its medicines in over 100 countries. Learn more at or connect with us on LinkedIn, Instagram, YouTube, Facebook and X. REFERENCES 1 – Arce JC, Larsson P, Garcia-Velasco JA; Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa; RBMO; 2020 2 – Yang R, Zhang Y, Liang X et al; Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization / intracytoplasmic sperm injection; Reproductive Biology and Endocrinology; 2022 3 – Clinical page: (Accessed June 2025) 4 – Andersen, A. N., Nelson, S. M., Fauser, B. et al. (2017). Individualized versus conventional ovarian stimulation for in vitro fertilization: A multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertility and Sterility, 107(2), 387-396. 5 – Bosch E, Havelock J, Martin FS, Rasmussen BB, Klein BM, Mannaerts B, Arce JC; ESTHER-2 Study Group. Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial. Reprod Biomed Online. 2019 Feb;38(2):195-205. PMID: 30594482. 6 – Ishihara O, Arce JC, Japanese Follitropin Delta Phase 3 Trial G. Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF/ICSI patients: a randomized controlled trial. Reprod Biomed Online. 2021 May;42(5):909-18. PubMed PMID: 33722477. Epub 2021/03/17. 7 – Qiao J, Zhang Y, Liang X, et al. A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients. Hum Reprod. 2021 Jun 28;36(9):2452-62. PubMed PMID: 34179971. Epub 2021/06/29. 8 – Blockeel C, Griesinger G, Rago R, et al. Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study). Frontiers in Endocrinology. 2022 Dec 22;13:992677. PMID: 36619578. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store